Search results for "Coronavirus"
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://acpinternist.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://acpinternist.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Oral medications for COVID-19 underused among socially vulnerable, CDC study finds
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
https://acpinternist.org/weekly/archives/2022/06/28/2.htm
28 Jun 2022
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://acpinternist.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://acpinternist.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022
Studies examine persistent symptoms of COVID-19
A U.K. study found that COVID-19 vaccination after infection may help persistent symptoms, while a U.S. study found that the burden of such symptoms appears high.
https://acpinternist.org/weekly/archives/2022/05/24/5.htm
24 May 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19
During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
https://acpinternist.org/weekly/archives/2022/02/01/2.htm
1 Feb 2022
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://acpinternist.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VII: Challenging Clinical Questions
During the Dec. 8 virtual live event, a panel of experts will provide answers to common questions about COVID-19 that physicians face today.
https://acpinternist.org/weekly/archives/2021/11/23/2.htm
23 Nov 2021
Latest pandemic research looks at persistent symptoms of COVID-19, rise in alcohol deaths
More than half of patients with mild COVID-19 reported symptoms months later in one study, while another found psychiatric and neurologic consequences were similar in ICU survivors with and without COVID-19. Other research looked at the rise in alcohol-related deaths and the safety of vaccination during pregnancy.
https://acpinternist.org/weekly/archives/2022/03/29/4.htm
29 Mar 2022